Expand ALDX Menu

ALDX Stock Summary and Trading Ideas (Aldeyra Therapeutics | NASDAQ:ALDX)

Charts for Today's Stock Price and Implied Volatility in Aldeyra Therapeutics


Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for ALDX by Theoretical Edge and Win Rates



FDA says more studies needed to approve Aldeyra dry eye drug

Seeking Alpha News (Mon, 27-Nov 5:02 PM ET)

FDA says more data needed to approve Aldeyra dry eye drug (update)

Seeking Alpha News (Mon, 27-Nov 5:02 PM ET)

Trading Statistics

Key Ratios

Aldeyra Therapeutics (ALDX) Frequently Asked Questions

What does Aldeyra Therapeutics do?

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. The company's product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer.

What symbol and exchange does Aldeyra Therapeutics stock trade?

Aldeyra Therapeutics trades on the NASDAQ stock market under the symbol ALDX.

What is Aldeyra Therapeutics stock price doing today?

As of November 27, 2023, ALDX stock price climbed to $2.62 with 979,762 million shares trading.

What is Aldeyra Therapeutics's Beta?

ALDX has a beta of 4.30, meaning it tends to be more sensitive to market movements. ALDX has a correlation of 0.18 to the broad based SPY ETF.

How much is Aldeyra Therapeutics worth?

ALDX has a market cap of $154.11 million. This is considered a Micro Cap stock.

What is the highest and lowest price Aldeyra Therapeutics traded in the last 3 year period?

In the last 3 years, ALDX stock traded as high as $15.95 and as low as $1.42.

What are the top ETFs holding Aldeyra Therapeutics?

The top ETF exchange traded funds that ALDX belongs to (by Net Assets): XBI, IWM, VTI, VXF, IWO.

Is Aldeyra Therapeutics (ALDX) a good investment?

ALDX has underperformed the market in the last year with a return of -51.3%, while the SPY ETF gained +14.6%. In the last 3 month period, ALDX fell short of the market, returning -64.4%, while SPY returned +4.4%. However, in the most recent 2 weeks ALDX has outperformed the stock market by returning +14.7%, while SPY returned +3.1%.

What is the support and resistance for Aldeyra Therapeutics (ALDX) stock price?

ALDX support price is $2.34 and resistance is $2.72 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ALDX stock will trade within this expected range on the day.